Question 10493 — victim assistance

Summary

Mrs. Anne-Sophie Ronceret draws the attention of the Minister of Health, Families, Autonomy and Persons with Disabilities to the situation of patients suffering from serious adverse effects following the use of synthetic progestins, in particular cyproterone acetate (Androcur), Lutényl or Lutéran. Indeed, prescribed for several decades for various indications, these drugs have been the subject of alerts from the Agency National Safety of Medicines and Health Products (ANSM) from 2018 due to an increased risk of meningiomas, non-cancerous brain tumors that can cause serious after-effects. However, many patients indicate that information relating to this risk was partially known well before this date. To date, several hundred files have been compiled and dozens of procedures legal or amicable proceedings are underway, some of which have already led to the recognition of a causal link between the consumption of these medications and the occurrence of meningiomas. Consequently, in order to avoid long and trying litigation processes and to guarantee fair compensation, the study of an amicable compensation system is mentioned by various stakeholders. Such a mechanism would allow, where appropriate, expertise on parts, harmonization of practices and shorter instruction times. Also, she asks him if the Government plans to put in place such an amicable compensation system for patients suffering from meningiomas linked to the use of synthetic progestins, in order to guarantee fair compensation and to spare these victims a long and trying legal process.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.